drugset / Trial / NCT03916640
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
RandomizedCrossoverTriple-blindTreatment
Summary
This trial is a monocentric, randomised, double-blind, active comparator, controlled, 3-period cross-over trial.
Timeline
- Start
- 2019-01-04
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADO09 | Unknown | — | Subcutaneous |
| Comparator | Insulin | Protein / enzyme biologic | — | Subcutaneous |
| Comparator | Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |
| Comparator | Pramlintide | Peptide | — | Subcutaneous |